首页|期刊导航|Oncology Research|PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway

PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway

Lei Luo Fengju Guan Zhankun Wang Bin Li Xuemei Ding Leilei Song Lijiang Sun

Oncology Research2026，Vol.34Issue(7)：P.666-687,22.

Oncology Research2026，Vol.34Issue(7)：P.666-687,22.DOI:10.32604/or.2026.080621

PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway

Lei Luo ¹Fengju Guan ¹Zhankun Wang ²Bin Li ¹Xuemei Ding ¹Leilei Song ¹Lijiang Sun¹

作者信息

1. Urological Department,The Affiliated Hospital of Qingdao University,No.16,Jiangsu Road,Shinan District,Qingdao,China
2. Urological Department,Qingdao Eighth People’s Hospital,No.84,Fengshan Road,Licang District,Qingdao,China
折叠

摘要

关键词

Clear cell renal cell carcinoma/PARP9/STAT1/IRF1 signaling pathway/sunitinib resistance/ISG15

分类

医药卫生

引用本文复制引用

Lei Luo,Fengju Guan,Zhankun Wang,Bin Li,Xuemei Ding,Leilei Song,Lijiang Sun..PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway[J].Oncology Research,2026,34(7):P.666-687,22.

基金项目

funded by the Special Fund for Clinical Research of Wu Jieping Medical Foundation(320.6750.2025-02-7) （320.6750.2025-02-7）

the Horizontal Research Project of the Affiliated Hospital of Qingdao University and Yunnan Yunke Biotechnology Institution(5212). （5212）

Oncology Research

ISSN：0965-0407

访问量0

下载量0

段落导航